Ann Mohrbacher

982 total citations
18 papers, 408 citations indexed

About

Ann Mohrbacher is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Ann Mohrbacher has authored 18 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 8 papers in Public Health, Environmental and Occupational Health and 8 papers in Hematology. Recurrent topics in Ann Mohrbacher's work include Acute Lymphoblastic Leukemia research (8 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Acute Myeloid Leukemia Research (4 papers). Ann Mohrbacher is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Acute Myeloid Leukemia Research (4 papers). Ann Mohrbacher collaborates with scholars based in United States. Ann Mohrbacher's co-authors include Dan Douer, Stephanie A. Gregory, Mohamad A. Hussein, Robert M. Rifkin, Vinod Pullarkat, Ibrahim Aldoss, Lisa Mark, Laleh Ramezani, Matthew A. Lunning and Patrick W. Burke and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Ann Mohrbacher

18 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Mohrbacher United States 9 187 152 133 115 108 18 408
Fataneh Majlessipour United States 6 293 1.6× 241 1.6× 62 0.5× 90 0.8× 49 0.5× 13 431
Ashish Masurekar United Kingdom 6 215 1.1× 101 0.7× 144 1.1× 83 0.7× 108 1.0× 9 358
Joanna Zawitkowska Poland 11 173 0.9× 92 0.6× 121 0.9× 126 1.1× 115 1.1× 61 386
Orsolya Lautner‐Csorba United States 11 121 0.6× 114 0.8× 31 0.2× 67 0.6× 89 0.8× 18 333
Takeo Fujimoto Japan 11 109 0.6× 35 0.2× 178 1.3× 187 1.6× 67 0.6× 32 388
Maria Scalzone Italy 9 36 0.2× 41 0.3× 72 0.5× 78 0.7× 51 0.5× 15 309
Junjie Fang China 8 71 0.4× 22 0.1× 81 0.6× 174 1.5× 90 0.8× 16 468
Chelsea L. Dieck United States 5 43 0.2× 22 0.1× 18 0.1× 70 0.6× 36 0.3× 9 168
Oscar González‐Ramella Mexico 10 44 0.2× 39 0.3× 56 0.4× 88 0.8× 92 0.9× 28 359
Qianqian Hou China 9 48 0.3× 25 0.2× 15 0.1× 76 0.7× 48 0.4× 16 210

Countries citing papers authored by Ann Mohrbacher

Since Specialization
Citations

This map shows the geographic impact of Ann Mohrbacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Mohrbacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Mohrbacher more than expected).

Fields of papers citing papers by Ann Mohrbacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Mohrbacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Mohrbacher. The network helps show where Ann Mohrbacher may publish in the future.

Co-authorship network of co-authors of Ann Mohrbacher

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Mohrbacher. A scholar is included among the top collaborators of Ann Mohrbacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Mohrbacher. Ann Mohrbacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Iyer, Swaminathan P., Auris Huen, Weiyun Z. Ai, et al.. (2023). Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study. Haematologica. 109(1). 209–219. 16 indexed citations
2.
Iyer, Swaminathan P., Auris Huen, Weiyun Z. Ai, et al.. (2021). Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell Lymphoma: Final Results from a Phase I/II Open Label Multi-Center Study. Blood. 138(Supplement 1). 1365–1365. 12 indexed citations
3.
Burke, Patrick W., Ibrahim Aldoss, Matthew A. Lunning, et al.. (2018). Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses. Leukemia Research. 66. 49–56. 27 indexed citations
4.
Merin, Noah, Ann Mohrbacher, George Yaghmour, et al.. (2018). Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia. Leukemia Research Reports. 9. 18–20. 9 indexed citations
5.
Mohrbacher, Ann, Allen S. Yang, Susan Groshen, et al.. (2017). Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial. Clinical Cancer Research. 23(16). 4550–4555. 28 indexed citations
6.
Kang, Irene, Dongyun Yang, Mi Hee Park, et al.. (2016). Racial/Ethnic Disparities in NK/T-Cell Non-Hodgkin Lymphomas in the US: A SEER Analysis. Blood. 128(22). 3612–3612. 1 indexed citations
7.
Aldoss, Ibrahim, Dan Douer, Carolyn E. Behrendt, et al.. (2015). Toxicity profile of repeated doses of PEG‐asparaginase incorporated into a pediatric‐type regimen for adult acute lymphoblastic leukemia. European Journal Of Haematology. 96(4). 375–380. 62 indexed citations
8.
9.
Burke, Patrick W., Ibrahim Aldoss, Laleh Ramezani, et al.. (2014). Frequency and Characteristics of Pegaspargase Antibodies in Adults Treated with a Pediatric Acute Lymphoblastic Leukemia Regimen. Blood. 124(21). 936–936. 1 indexed citations
10.
Douer, Dan, Ibrahim Aldoss, Matthew A. Lunning, et al.. (2014). Pharmacokinetics-Based Integration of Multiple Doses of Intravenous Pegaspargase in a Pediatric Regimen for Adults With Newly Diagnosed Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 32(9). 905–911. 84 indexed citations
11.
Aldoss, Ibrahim, Vinod Pullarkat, Kristy Watkins, et al.. (2013). An effective reinduction regimen for first relapse of adult acute lymphoblastic leukemia. Medical Oncology. 30(4). 744–744. 6 indexed citations
12.
13.
14.
Jakubowiak, Andrzej, Don M. Benson, William Bensinger, et al.. (2010). Elotuzumab In Combination with Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma: Updated Results of a Phase 1 Study. Blood. 116(21). 3023–3023. 7 indexed citations
15.
Pullarkat, Vinod, et al.. (2007). Therapy-related, mixed-lineage leukaemia translocation-positive, monoblastic myeloid sarcoma of the uterus. Journal of Clinical Pathology. 60(5). 562–564. 5 indexed citations
16.
17.
18.
Douer, Dan, Kristy Watkins, Ilene C. Weitz, et al.. (2005). Treatment of Non-APL Acute Myelogenous Leukemia with Intravenous Arsenic Trioxide Plus Ascorbic Acid.. Blood. 106(11). 4603–4603. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fataneh Majlessipour Breakdown of academic impact, for papers by Ashish Masurekar Breakdown of academic impact, for papers by Joanna Zawitkowska Breakdown of academic impact, for papers by Orsolya Lautner‐Csorba Breakdown of academic impact, for papers by Takeo Fujimoto Breakdown of academic impact, for papers by Maria Scalzone Breakdown of academic impact, for papers by Junjie Fang Breakdown of academic impact, for papers by Chelsea L. Dieck Breakdown of academic impact, for papers by Oscar González‐Ramella Breakdown of academic impact, for papers by Qianqian Hou
Rankless by CCL
2026